Literature DB >> 33740206

Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN).

Roland D Thijs1,2, Michele Brignole3,4, Cristian Falup-Pecurariu5, Alessandra Fanciulli6, Roy Freeman7, Pietro Guaraldi8, Jens Jordan9,10,11, Mario Habek12, Max Hilz13,14, Anne Pavy-Le Traon15, Iva Stankovic16, Walter Struhal17, Richard Sutton18, Gregor Wenning6, J Gert Van Dijk19.   

Abstract

An expert committee was formed to reach consensus on the use of tilt table testing (TTT) in the diagnosis of disorders that may cause transient loss of consciousness (TLOC) and to outline when other provocative cardiovascular autonomic tests are needed. While TTT adds to history taking, it cannot be a substitute for it. An abnormal TTT result is most meaningful if the provoked event is recognised by patients or eyewitnesses as similar to spontaneous events. The minimum requirements to perform TTT are a tilt table, a continuous beat-to-beat blood pressure monitor, at least one ECG lead, protocols for the indications stated below and trained staff. This basic equipment lends itself to the performance of (1) additional provocation tests, such as the active standing test, carotid sinus massage and autonomic function tests; (2) additional measurements, such as video, EEG, transcranial Doppler, NIRS, end-tidal CO2 or neuro-endocrine tests; and (3) tailor-made provocation procedures in those with a specific and consistent trigger of TLOC. TTT and other provocative cardiovascular autonomic tests are indicated if the initial evaluation does not yield a definite or highly likely diagnosis, but raises a suspicion of (1) reflex syncope, (2) the three forms of orthostatic hypotension (OH), i.e. initial, classic and delayed OH, as well as delayed orthostatic blood pressure recovery, (3) postural orthostatic tachycardia syndrome or (4) psychogenic pseudosyncope. A therapeutic indication for TTT is to teach patients with reflex syncope and OH to recognise hypotensive symptoms and to perform physical counter manoeuvres.

Entities:  

Keywords:  Orthostatic hypotension; Psychogenic pseudosyncope; Reflex syncope; Syncope; Tilt table testing; Transient loss of consciousness; Vasovagal

Year:  2021        PMID: 33740206     DOI: 10.1007/s10286-020-00738-6

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  76 in total

Review 1.  Tilt table testing in neurology and clinical neurophysiology.

Authors:  D P Saal; R D Thijs; J G van Dijk
Journal:  Clin Neurophysiol       Date:  2015-09-08       Impact factor: 3.708

2.  High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the Fainting Assessment study.

Authors:  Nynke van Dijk; Kimberly R Boer; Nancy Colman; Annemieke Bakker; Jan Stam; Johannes J M van Grieken; Arthur A M Wilde; Mark Linzer; Johannes B Reitsma; Wouter Wieling
Journal:  J Cardiovasc Electrophysiol       Date:  2007-10-03

3.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

Authors:  Roy Freeman; Wouter Wieling; Felicia B Axelrod; David G Benditt; Eduardo Benarroch; Italo Biaggioni; William P Cheshire; Thomas Chelimsky; Pietro Cortelli; Christopher H Gibbons; David S Goldstein; Roger Hainsworth; Max J Hilz; Giris Jacob; Horacio Kaufmann; Jens Jordan; Lewis A Lipsitz; Benjamin D Levine; Phillip A Low; Christopher Mathias; Satish R Raj; David Robertson; Paola Sandroni; Irwin Schatz; Ron Schondorff; Julian M Stewart; J Gert van Dijk
Journal:  Clin Auton Res       Date:  2011-04       Impact factor: 4.435

4.  History taking as a diagnostic test in patients with syncope: developing expertise in syncope.

Authors:  Wouter Wieling; Nynke van Dijk; Frederik J de Lange; Louise R A Olde Nordkamp; Roland D Thijs; J Gert van Dijk; Mark Linzer; Richard Sutton
Journal:  Eur Heart J       Date:  2014-12-16       Impact factor: 29.983

5.  2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Win-Kuang Shen; Robert S Sheldon; David G Benditt; Mitchell I Cohen; Daniel E Forman; Zachary D Goldberger; Blair P Grubb; Mohamed H Hamdan; Andrew D Krahn; Mark S Link; Brian Olshansky; Satish R Raj; Roopinder Kaur Sandhu; Dan Sorajja; Benjamin C Sun; Clyde W Yancy
Journal:  Heart Rhythm       Date:  2017-03-09       Impact factor: 6.343

Review 6.  Tilt testing for syncope: a reappraisal.

Authors:  Robert Sheldon
Journal:  Curr Opin Cardiol       Date:  2005-01       Impact factor: 2.161

7.  Blood pressure changes on upright tilting predict falls in older people.

Authors:  Edward Heitterachi; Stephen R Lord; Phillip Meyerkort; Ian McCloskey; Richard Fitzpatrick
Journal:  Age Ageing       Date:  2002-05       Impact factor: 10.668

Review 8.  Abolish the Tilt Table Test for the Workup of Syncope!

Authors:  Nitin Kulkarni; Purav Mody; Benjamin D Levine
Journal:  Circulation       Date:  2020-02-03       Impact factor: 29.690

9.  Letter by Sutton et al Regarding Article, "Abolish the Tilt Table Test for the Workup of Syncope!"

Authors:  Richard Sutton; Artur Fedorowski; David G Benditt
Journal:  Circulation       Date:  2020-06-22       Impact factor: 29.690

10.  Depressive Symptoms and Orthostatic Hypotension Are Risk Factors for Unexplained Falls in Community-Living Older People.

Authors:  Jasmine C Menant; Alfred K W Wong; Julian N Trollor; Jacqueline C T Close; Stephen R Lord
Journal:  J Am Geriatr Soc       Date:  2016-05       Impact factor: 5.562

View more
  8 in total

1.  What is the best method to diagnose a vasovagal syncope?

Authors:  Wouter Wieling; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2021-05-07       Impact factor: 4.435

2.  Comparison of pain-provoked versus standard 40-min tilt table test for the conformation of vasovagal syncope.

Authors:  Ivan Adamec; Anamari Junaković; Magdalena Krbot Skorić; Mario Habek
Journal:  Neurol Sci       Date:  2022-04-21       Impact factor: 3.830

3.  A new light on an old condition.

Authors:  Walter Struhal; Barbara Hain
Journal:  Eur Heart J Case Rep       Date:  2021-12-14

Review 4.  Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS.

Authors:  Amanda K Morrow; Laura A Malone; Christina Kokorelis; Lindsay S Petracek; Ella F Eastin; Katie L Lobner; Luise Neuendorff; Peter C Rowe
Journal:  Curr Pediatr Rep       Date:  2022-03-09

5.  The prevalence and impact of orthostatic intolerance in young women across the hypermobility spectrum.

Authors:  Karen C Peebles; Isabella Tan; Mark Butlin; Felicity Collins; Louise Tofts; Alberto P Avolio; Verity Pacey
Journal:  Am J Med Genet A       Date:  2022-02-27       Impact factor: 2.578

6.  Orthostatic stress response in pediatric Fontan patients and the effect of ACE inhibition.

Authors:  Lisette M Harteveld; Nico A Blom; J Gert van Dijk; Robert H Reijntjes; Paul J van Someren; Fabian I Kerkhof; Irene M Kuipers; Lukas A J Rammeloo; Eco J C de Geus; Arend D J Ten Harkel
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

7.  Postural orthostatic tachycardia syndrome as a sequela of COVID-19.

Authors:  Cameron K Ormiston; Iwona Świątkiewicz; Pam R Taub
Journal:  Heart Rhythm       Date:  2022-07-16       Impact factor: 6.779

8.  Feasibility of Blood Pressure Measurement With a Wearable (Watch-Type) Monitor During Impending Syncopal Episodes.

Authors:  Antonella Groppelli; Martina Rafanelli; Giuseppe Dario Testa; Samuele Agusto; Giulia Rivasi; Andrea Ungar; Erika Carbone; Davide Soranna; Antonella Zambon; Michele Brignole; Gianfranco Parati
Journal:  J Am Heart Assoc       Date:  2022-08-05       Impact factor: 6.106

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.